Orbital mass as manifestation of Wegener's granulomatosis: An ophthalmologic diagnostic approach

Clinical and Experimental Rheumatology

Volumn 29, Issue 1 SUPPL. 64, 2011, Pages

  Bijlsma, Ward R ^a   Hene R J ^a   Mourits, M P ^b   Kalmann, R ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Diagnosis; Orbit inflammation; Orbital mass; Sarcoidosis; Wegener

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; NEUTROPHIL CYTOPLASMIC ANTIBODY;

ADOLESCENT; ADULT; AGED; ANTIBODY DETECTION; ARTICLE; ASPERGILLOSIS; CHILD; CLINICAL ARTICLE; CORTICOSTEROID THERAPY; DIFFERENTIAL DIAGNOSIS; DIPLOPIA; DISEASE DURATION; EXOPHTHALMOS; EYE MOVEMENT DISORDER; EYE SURGERY; EYE SWELLING; FEMALE; GRANULOMATOUS VASCULITIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; ORBIT DISEASE; ORBIT INFLAMMATION; ORBIT WEGENER GRANULOMATOSIS; PRIORITY JOURNAL; SARCOIDOSIS; SCHOOL CHILD; THYROID FUNCTION TEST; VISUAL IMPAIRMENT; WEGENER GRANULOMATOSIS; CONTROLLED STUDY; EAR; NOSE; OCULAR SARCOIDOSIS; THROAT; VASCULITIS;

ADOLESCENT; ADULT; AGED; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; BIOLOGICAL MARKERS; BIOPSY; CHILD; DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC TECHNIQUES, OPHTHALMOLOGICAL; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NASAL MUCOSA; NETHERLANDS; ORBIT; ORBITAL DISEASES; PARANASAL SINUSES; PREDICTIVE VALUE OF TESTS; REFERRAL AND CONSULTATION; TOMOGRAPHY, X-RAY COMPUTED; WEGENER GRANULOMATOSIS; YOUNG ADULT;

EID: 79960428389     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. HOFFMAN GS, KERR GS, LEAVITT RY et al.: Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med 1992; 116: 488-98.
2. PHILLIP R, LUQMANI R: Mortality in systemic vasculitis: a systematic review. Clin Exp Rheumatol 2008; 26 (Suppl. 51): S94-104.
3. DE LK, BIJZET J, VAN DER GRAAF AM et al.: Patients with Wegener's granulomatosis: a long-term follow-up study. Clin Exp Rheumatol 2010; 28: 18-23.
4. HAYNES BF, FISHMAN ML, FAUCI AS, WOLFF SM: The ocular manifestations of Wegener's granulomatosis. Fifteen years experience and review of the literature. Am J Med 1977; 63: 131-41.
5. SEO P, STONE JH: The antineutrophil cytoplasmic antibody-associated vasculitides. Am J Med 2004; 117:39-50.
6. STONE JH: Limited versus severe Wegener's granulomatosis: baseline data on patients in the Wegener's granulomatosis etanercept trial. Arthritis Rheum 2003; 48: 2299-309.
7. COURCOUTSAKIS NA, LANGFORD CA, SNELLER MC et al.: Orbital involvement in Wegener granulomatosis: MR findings in 12 patients. J Comput Assist Tomogr 1997; 21: 452-8.
8. WOO TL, FRANCIS IC, WILCSEK GA et al.: Australasian orbital and adnexal Wegener's granulomatosis. Ophthalmology 2001; 108: 1535-43.
9. PERRY SR, ROOTMAN J, WHITE VA: The clinical and pathologic constellation of Wegener granulomatosis of the orbit. Ophthalmology 1997; 104: 683-94.
10. FECHNER FP, FAQUIN WC, PILCH BZ: Wegener's granulomatosis of the orbit: a clinicopathological study of 15 patients. Laryngoscope 2002; 112: 1945-50.
11. KALINA PH, LIE JT, CAMPBELL RJ, GARRITY JA: Diagnostic value and limitations of orbital biopsy in Wegener's granulomatosis. Ophthalmology 1992; 99: 120-4.
12. AHMED M, NIFFENEGGER JH, JAKOBIEC FA et al.: Diagnosis of limited ophthalmic Wegener granulomatosis: distinctive pathologic features with ANCA test confirmation. Int Ophthalmol 2008; 28: 35-46.
13. LEAVITT RY, FAUCI AS, BLOCH DA et al.: The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. Arthritis Rheum 1990; 33: 1101-7.
14. BHATIA A, YADAVA U, GOYAL JL, CHATURVEDI KU: Limited Wegener's granulomatosis of the orbit: a case study and review of literature. Eye 2005; 19: 102-4.
15. KNOCH DW, LUCARELLI MJ, DORTZBACH RK, SMITH ME: Limited Wegener granulomatosis with 40 years of follow-up. Arch Ophthalmol 2003; 121: 1640-2.
16. KOPSTEIN AB, KRISTOPAITIS T, GUJRATI TM et al.: Orbital Wegener granulomatosis without systemic findings. Ophthal Plast Reconstr Surg 1999; 15: 467-9.
17. FINKIELMAN JD, LEE AS, HUMMEL AM et al.: ANCA are detectable in nearly all patients with active severe Wegener's granulomatosis. Am J Med 2007; 120: 643-14.
18. HOLLE JU, WU QJ, MOOSIG F et al.: Membrane proteinase 3 (mPR3) expression on neutrophils is not increased in localized Wegener's granulomatosis (WG) and ChurgStrauss syndrome (CSS). Clin Exp Rheumatol 2010; 28: 46-50.
19. CHEN M, KALLENBERG CG: New advances in the pathogenesis of ANCA-associated vasculitides. Clin Exp Rheumatol 2009; 27 (Suppl.52): S108-S114.
20. BOUDES P: Purely granulomatous Wegener's granulomatosis: a new concept for an old disease. Semin Arthritis Rheum 1990; 19: 365-70.
21. TARABISHY AB, SCHULTE M, PAPALIODIS GN, HOFFMAN GS: Wegener's granulomatosis: clinical manifestations, differential diagnosis, and management of ocular and systemic disease. Surv Ophthalmol 2010; 55: 429-44.